1385. Pathway with single-dose long-acting intravenous antibiotic dalbavancin is a cost-saving alternative to usual inpatient care of acute bacterial skin and skin structure infections (ABSSSI)

BACKGROUND: Acute bacterial skin and skin structure infections (ABSSSI) are a common type of bacterial infection, with the cost of hospitalization being the main contributing factor to overall treatment costs. Two pragmatic clinical trials (Table 1) demonstrated that a new treatment pathway in which...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovecchio, Frank, Henry, Alasdair D, Doan, Quan V, Lock, John L, Lyles, Rosie D, Ye, Xiaolan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752577/
http://dx.doi.org/10.1093/ofid/ofac492.1214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752577/
http://dx.doi.org/10.1093/ofid/ofac492.1214

Ejemplares similares